Skinny Labels at the Supreme Court: Carving Out Room for Generics to Breathe
HIKMA PHARMACEUTICALS USA INC. et al. v. AMARIN PHARMA, INC., et al. Jackson, J., delivered the opinion for a unanimous Court. Certiorari to the United States Court of Appeals for...
4th Annual MCLE-a-thon: Federal Funding & Legal Landmines: A Guide for In‑House Teams
As part of the firm’s 4th annual MCLE‑a‑thon, Lance D. Smemoe provides a practical overview of the intellectual property risks associated with federal funding and government contracts. Lance discusses how...
Jarom Kesler Comments on USPTO Ex Parte Reexamination Denial Trends in Law360
In the Law360 article “USPTO Clamping Down Reexam Bids After IPR Denials,” Knobbe Martens partner Jarom Kesler shared how a recent ruling from the U.S. Patent and Trademark Office (USPTO)...